1. Home
  2. NPKI vs MLTX Comparison

NPKI vs MLTX Comparison

Compare NPKI & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

HOLD

Current Price

$13.53

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$16.21

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPKI
MLTX
Founded
1932
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NPKI
MLTX
Price
$13.53
$16.21
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$14.17
$30.58
AVG Volume (30 Days)
722.6K
933.3K
Earning Date
04-30-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.60
N/A
Revenue Next Year
$12.80
N/A
P/E Ratio
$38.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.76
$5.95
52 Week High
$15.85
$62.75

Technical Indicators

Market Signals
Indicator
NPKI
MLTX
Relative Strength Index (RSI) 44.55 40.75
Support Level $13.31 $14.84
Resistance Level $14.00 $16.69
Average True Range (ATR) 0.51 0.72
MACD -0.03 -0.28
Stochastic Oscillator 33.97 1.10

Price Performance

Historical Comparison
NPKI
MLTX

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: